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Title:   
Tuberculosis in medical doctors in KwaZulu-Natal (South Africa): Personal 
experiences and reflections related to their diagnosis and treatment. 
 
Background: 
The high tuberculosis (TB) incidence and prevalence fuelled by the concomitant 
HIV epidemic in South Africa has resulted in a high rate of tuberculosis infection 
in health care workers. This is the first study to investigate the experiences and 
reflections of doctors who were diagnosed with active TB during their 
employment in high TB burden hospitals in KwaZulu-Natal, South Africa. 
 
Methods: 
Consecutive medical doctors working in both the public and private sectors and 
who were treated for active tuberculosis between 2007 and 2010 were 
contacted to participate in the study. Each participant completed an informed 
consent and a validated anonymous self-administered questionnaire. The study 
received ethical approval from the University of KwaZulu-Natal. 
 
Results: 
Forty doctors participated in the study. The mean age of participants was 
33.67±10.63 years. The majority were between 21 and 40 years of age (males 
(52.5%), and employed in the public sector (95%). Four (10%) had MDR-TB. A 
number of participants were referred for costly special investigations which are 
not considered to be part of first line care in South Africa. For example, 15 
x 
 
participants (37.5%) underwent chest CAT scans during the diagnostic period. 
Eight doctors reported complications following invasive procedures. 
 
Nineteen (47.5%) of the 33 participants (82.5%) who had experienced side-
effects related to anti-TB drugs had considered defaulting on their treatment 
because of the side-effects of these drugs. Many participants expressed 
concerns about the uncaring attitudes of senior medical colleagues and hospital 
management. The majority of participants had introspected on their illnesses 
and experiences and committed themselves to become more caring and 
empathic towards their patients in future. 
 
Conclusions: 
All health care workers and particularly nurses and medical doctors working in 
environments with a high burden of infectious diseases such as HIV and TB, are 
at increased risk to TB infection. They encounter various personal and 
professional problems following contraction of TB infection. These experiences 
had impacted in many ways on their professional lives, and some doctors have 
since left the medical profession because of these experiences. The risks 
associated with TB must be minimised. Much more therefore remains to be 
done in the public health care system if these trends are to be reversed; this 
includes health policy changes, health system changes and attitudes of medical 
colleagues towards medical doctors who become “victims of illnesses acquired 









 1.1 Introduction  
 
The current tuberculosis (TB) epidemic sweeping through South Africa is 
considered to be one of the worst in the world; it has a high burden of disease, 
incidence rate, and Human immunodeficiency virus (HIV) co-infection rates. 
Additionally, it is accompanied by an increasing rate of drug resistance (Abdool 
Karim et al., 2009).The incidence of TB in South Africa has risen from 556 cases 
per 100 000 population in 2002 to an estimated 600 per 100 000 population in 
2007(National Department of Health, 2007). This epidemic is being fuelled by the 
concomitant HIV epidemic (Abdool Karim et al., 2009, Padayatchi et al., 2010). 
 
Occupational exposure towards TB constitutes a major health hazard for all health 
care workers (HCW) throughout the world, and especially in developing and 
resource-constrained countries or settings (Ramphal-Naley et al., 1996, Kruuner et 
al., 2001, Plitt et al., 2001, Bonifacio et al., 2002, Yanai et al., 2003, Laniado-
Laborin and Cabrales-Vargas, 2006, Galgalo et al., 2008, Deribew et al., 2009). 
 
Although sub-Saharan Africa has the highest rates of TB in the world, the rates of 
TB among health care workers are poorly documented (Naidoo and Jinabhai, 
2006). Further, whilst many studies have been conducted globally on the 
psychological impact of TB on general populations, there is minimal evidence of 




Medical doctors are at great risk of acquiring TB whilst on duty in both public and 
private health care facilities, and especially in the resource-constrained and heavily 
disease burdened public health care sector (Naidoo and Jinabhai, 2006, Padayatchi 
et al., 2010). The risk of acquiring any nosocomial infection and especially drug-
resistant Mycobacterium TB is also increased by virtue of working in close proximity 
to infected patients and other staff who have co-existent HIV infection, and 
therefore compromised immunity and increased susceptibility to opportunistic 
infections.  
 
1.2 Problem statement 
 
 
There are no published reports on the experiences of medical doctors infected with 
TB during the period of symptom and sign presentation, diagnosis and 
management of their illnesses. There is also minimal information currently available 
on how medical doctors cope during their illnesses (Padayatchi et al., 2010).  
 
1.3 Rationale for study 
 
 
This study will contribute enormously to current knowledge on the personal 
experiences, impact and reflections of medical doctors with active TB infection 
acquired through nosocomial transmission or re-activation of pre-existing disease, 
especially those who are working in the public health care sector. It will also provide 
a better understanding of the feelings of such doctors towards their medical 
colleagues, hospital management and their current practice of medicine. 
This study will enable us to gain valuable insight into the help-seeking behaviour of 
medical doctors with overt or covert presentations suggestive of TB infection, their 
interactions with the health care system to seek treatment, and the attitudes of 
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management and fellow colleagues in the work place towards them following 
diagnosis and treatment. 
 
1.4 Study hypothesis  
 




1.5 Aim of study 
 
This study investigated the personal experiences and reflections of medical doctors 
infected with TB towards diagnosis and treatment of their illness. 
 
1.6 Objectives of study 
 
 
In order to achieve the aim, the following specific objectives were pursued: 
 
 
i. To describe the demographic profile of medical doctors diagnosed with TB (in 
terms of race, age, sex, clinical discipline/place of employment, co-morbid 
disease). 
ii. To determine the symptoms and signs at the time of presentation. 
iii. To document the methods used in the diagnosis of infection with TB (sputum 
microscopy, culture; histological samples; clinical suspicion; radiological 
features). 
iv. To measure the time-lag or period from time of first symptoms to clinical 
presentation to date of diagnosis and commencement of pharmacotherapy and 
completion of pharmacotherapy. 
v. To ascertain the extent to which the generally accepted treatment guidelines 
(adopted by the National Department of Health) for the management of TB 
were followed when diagnosing and treating medical doctors. 
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vi. To determine the prevalence of side- effects or adverse effects of anti-TB drug 
therapy, and the methods used to overcome these side-effects. 
 
 
1.6 Organization of mini-thesis 
 
 
This chapter has provided an overview of the study including the background, the 
rationale for the study, the study aim and objectives. 
Chapter two describes a review of the literature relating to the burden of TB 
infection and care in KwaZulu-Natal, including the burden and impact of nosocomial 
TB on health care workers especially those in constant contact with patients 
infected with the Human immunodeficiency virus (HIV) and Mycobacterium 
tuberculosis, such as nurses and medical doctors. 
Chapter three presents a description of the study methodology.  
Chapter four presents the results and findings of the study.  
Discussion and conclusions emanating from the findings are presented in Chapter 
five. 

















A literature search was done using the Medline database. The key words that were  
 




The following themes are reflected in this review of the literature: 
 
i. Incidence and prevalence of TB infection in health care workers  
globally and in South Africa 
ii. Perceptions towards TB infection by general patients and health care 
workers 
iii. Impact of TB on lives of patients with tuberculosis infection 
iv. Adherence to TB medications 
v. Interventions and programmes to reduce nosocomial transmission of TB 
infection 
 
2.1 Incidence and prevalence of tuberculosis in hea lth care workers 
 
 
Tuberculosis has reached epidemic proportions in Sub-Saharan Africa (Abdool 
Karim et al., 2009). The incidence of TB in South Africa has risen from 556 cases 
per 100 000 population in 2002 to an estimate of 600 per 100 000 population in 
2007 (National Department of Health, 2007). This epidemic is being fuelled by the 
HIV epidemic (Abdool Karim et al., 2009, Padayatchi et al., 2010).  A study by 
Colvin et al.( 2001) found that the prevalence of HIV and HIV related diseases and  
TB  in adult medical wards in a tertiary hospital in KwaZulu-Natal (South Africa) was 
high (Colvin et al., 2001). They studied 507 in-patients, and found that 54% were 
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infected with HIV and pulmonary TB was present in 56% of HIV cases. The World 
Health Organization(WHO)  Global TB report for 2005 estimated that 61% of TB 
patients in South Africa were HIV co-infected (World Health Organisation, 2005). 
 
Occupational exposure towards TB constitutes a major health hazard for all health 
care workers (HCW) throughout the world, and especially in developing and 
resource-constrained countries or settings (Kruuner et al., 2001, Plitt et al., 2001, 
Bonifacio et al., 2002, Yanai et al., 2003, Laniado-Laborin and Cabrales-Vargas, 
2006, Galgalo et al., 2008, Deribew et al., 2009). Nosocomial outbreaks of TB 
among HCWs are well documented in many countries such as the United States of 
America (Menzies et al., 1995).  However, although sub-Saharan Africa has the 
highest rates of TB in the world, the rates of TB amongst HCWs are poorly 
documented (Naidoo and Jinabhai, 2006).  A recent study showed an alarming five 
to six fold increase in the incidence of hospital admissions for drug resistant TB 
among HCWs in KwaZulu-Natal, South Africa, compared to the general population 
 (O' Donnell et al., 2010). 
  
Whilst a number of general population studies have been conducted globally on the 
attitudes and psychological impact of contacting TB (Somma et al., 2008, Deribew 
et al., 2009, Zhang et al., 2010, Rundi, 2010, Karim et al., 2011),  little or no work 
has been done in this regard amongst health care workers generally and  
particularly among doctors who (by virtue of their nature of work) are at greater risk 
of being infected than the general population.  A qualitative study by Padayatchi et 
al. (2010) on the impact of  drug-resistant TB on five medical doctors in South 
Africa found that four of them experienced adverse effects due to medication, and 
in a few, these effects continued for several years after treatment was completed.  
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In addition, they found prolonged morbidity, psychological disturbances, poor 
infection control and support structures in their working environment, and attrition of 
doctors from the field. (Padayatchi et al., 2010)  However, there are no published 
reports on the experiences and reflections of TB infected doctors during the period 
relating to diagnosis, investigation, procedures and management. 
 
A  study in a local South African hospital concluded that the frequency of TB among 
staff had increased substantially between 1991 and 1996, and that this increase 
was associated with a rapidly expanding HIV epidemic in the community (Wilkinson 
and Gilks, 1998). It was further observed in this study that during this period the 
incidence of TB amongst HCWs (558 per 100 000) and ancillary staff (445 per100 
000) was not significantly different (p = 0.7), but was lower than the incidence 
among 20-59 year old people in the community (1543 per 100 000).  
 
Studies conducted within local hospitals in Malawi found that the TB infection rates 
were much higher amongst HCWs than amongst the general population (Harries et 
al., 1997, Harries et al., 1999, Harries et al., 2002, Kanyerere and Salaniponi, 
2003). In 1999, Harries and co-workers reported that the notification rate amongst 
HCWs within district hospitals in Blantyre was 12 times higher than the general 
population (Harries et al., 1999). A 2001 retrospective review of hospital records 
from a Malawi hospital demonstrated TB rates significantly higher in HCWs 
compared to the general population ( 5780  vs. 240 per 100 000 population) 
(Kanyerere and Salaniponi, 2003). The same study also found TB rates to be 
higher in patient attendants compared to nurses and doctors, and additionally found 
that many health care workers were incorrectly diagnosed as smear negative 




Failure to follow national guidelines in the diagnosis and treatment of TB generally 
can also influence nosocomial transmission and not improve notification rates. A 
study conducted in Somalia showed that few doctors followed the national 
guidelines (Suleiman et al., 2003). This cross-sectional study of 53 doctors working 
within the private and public sectors in North-Western Somalia reported inadequate 
knowledge among doctors regarding updated tuberculosis management protocols. 
The authors concluded that these findings posed a threat to TB control in Somalia 
(Suleiman et al., 2003).  
 
Other studies have shown that the risk of developing TB amongst HWCs was 
dependent on factors such as occupational category, age and use of TB infection 
control measures in the workplace (Wilkinson and Gilks, 1998, Ngamvithayapong et 
al., 2000, Alonso-Echanove et al., 2001). 
 
A review of KwaZulu-Natal (KZN) hospital records from the period 1999 to 2004 
conducted by Naidoo and Jinabhai, demonstrated an alarmingly high incidence of 
TB among HWCs, a high incidence in the younger age groups and poorer treatment 
outcomes. TB incidence among HCWs  during the study period was 1113(± 282.8) 
per 100 000 HCW(Naidoo and Jinabhai, 2006).  
 
2.2 Attitudes, perceptions and psycho-social attrib utes of patients towards 
tuberculosis  
 
Denials by patients of having contracted or suffering from tuberculosis have been 
an ongoing problem amongst the ordinary patients (Rowe et al., 2005, Jakubowiak 
et al., 2008, Karim et al., 2011). Karim and co-workers were of the view that this 
could be due to the social stigma attached to the conditions (Karim et al., 2011).  
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They found that this could account for non-adherence to treatment particularly in 
female patients in Bangladesh. Tuberculosis related stigma have been shown to 
worsen the quality of life of patients in that this perception or attitude could have an 
impact on help or health care seeking  behaviour (Somma et al., 2008, Weiss et al., 
2008). A study conducted in Russia showed that certain social circumstances ( 
such as unemployment, homelessness, imprisonment or poverty) and psychological 
factors (such as low or depressed mood, mood swings and having little confidence 
in medical staff) could account for the poor adherence to treatment (Jakubowiak et 
al., 2008). Similar findings have also been reported in a study conducted in Peru 
(Shin et al., 2008). A study undertaken in one of the impoverished islands of 
Malaysia where people lead a mainly  rural way of life, showed that patients with 
tuberculosis, who were not educated about the causes of TB , felt embarrassed 
about contracting the disease; additionally, the negative attitudes of healthcare staff 
inhibited  them from seeking treatment earlier (Rundi, 2010) . 
 
 




Most studies have shown clearly a direct relationship between the contraction of TB 
and social stigma (Rundi, 2010, Karim et al., 2011).  Such stigma associated  with 
the condition have led to social isolation and even living as a single person with 
poor prospect of marriage (Rundi, 2010).  This perceived and enacted stigma 
towards tuberculosis patients in East Malaysia included the practice of TB patients 
using separate utensils and deliberate acts of marginalising them socially from the 
community. The resultant psycho-social impact on their quality of life has been 
reported to be immense, and this included low self-esteem, and voluntary social 
withdrawal. All of these factors had contributed to a vicious cycle, and therefore 
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caused more hardship for patients. Patients in this study complained of weakness 
and never recovered fully from the infection (Rundi, 2010). These findings have 
been supported by other studies conducted by Zang et al. (2010) and by Karim et 
al. (2011). For example, students in Shaanxi province of China felt that their mental 
health was affected adversely following TB infection (Zhang et al., 2010). Other 
studies showed that the fear of infecting others  led to isolation from the rest of the 
family in some cases (Zhang et al., 2010, Karim et al., 2011) or  even depression 
and  suicidal behaviour (Shin et al., 2008, Rundi, 2010).  
 
 A study in India showed that TB patients had significantly worse quality of life 
compared to normal individuals especially in the physical and psychological 
domains. However, women patients had better scores in physical and psychological 
domains than male patients before the onset of treatment, inferring that women had 
better coping skills (Dhuria et al., 2009). In addition, they found that treatment 
improved all facets of quality of life but significant deficits still existed in social and 
environmental domains. Similar findings were observed in the United States of 
America (Hansel et al., 2004). In the latter study, TB was found to affect all 
predicted domains of quality of life such as general health perceptions, somatic 
sensations, psychological health, spiritual well-being, and physical, social and role 
functioning of patients. In addition, social stigmatization, isolation, pill burden, long 
duration of therapy, sexual dysfunction, loss of income, and fear were other specific 
predictors of quality of life identified in these patients.  
 
A study by Deribew and co-workers in Ethiopia revealed similar findings in that 
TB/HIV co-infected patients had a lower quality of life in all domains such as 
depression, diminished  income and less family support,  as compared to HIV 
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infected patients without active TB: (Deribew et al., 2009). Co-infected patients who 
had depression and did not have family support or income were more likely to have 
poor physical and psychological health as compared to individuals without 
depression, good family support and income (Deribew et al., 2009). Furthermore, 
this study found that stigma was associated with a poor quality of life in the 
psychological domain (Deribew et al., 2009). Similar findings were reported in a 
study undertaken in Equador which has the highest TB prevalence and incidence in 
the American regions (Armijos et al., 2008). The lifestyles of TB patients undergo 
significant changes when it comes to physical activity, diet and social activities. The 
participants in this study were of the view that these changes were necessary for 
the affected persons to get better or even cured and to reduce the rate of infecting 
others.  About 50% of the participants felt that being infected reduced one’s ability 
to adequately carry out one’s duties at the work place, home or at school. In 
addition, a significant number felt that TB impacted on the person’s paid 
employment because of TB-associated fatigue and malaise, and the constant need 
to seek treatment or rest reduced the number of hours of work in paid employment. 
The stigma that arose as a consequence of the infection were separated into two 
types. One was described as an internalised stigma where the participants 
indicated that they themselves suffered significant psychological and emotional 
distress, such as feeling of isolation, loneliness, sadness, or shame from learning 
that they had to be tested for TB and expressed being ashamed of having 
persistent and chronic cough.  Some of the participants were also worried that 
others would think that they were using their symptoms just as an excuse not to 
work. The other stigma was categorized as social stigma: the response from their 
social network, such as close friends, colleagues, family members or even their 
employers towards the patients on receiving the news that they were undergoing a 
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test for TB or being diagnosed as having TB. However, many indicated that the 
family members were very supportive towards them, and whilst some indicated that 
their employers were very supportive, others indicated that some of them were 
even dismissed from work on receiving the news of being TB inflicted (Armijos et 
al., 2008).The findings of this study in Equador relating to stigmatisation were 
supported by others (Hansel et al., 2004, Shin et al., 2008, Dhuria et al., 2009, 
Rundi, 2010, Zhang et al., 2010, Karim et al., 2011) . 
 
In a rural area of Bangladesh it was found that female patients were looked down 
upon by society. Whilst men expressed that they were able to cough up with an 
audible grunt and spit sputum anywhere, women on the other hand, could not do so 
in public and this led them to suppress their coughs and swallow their spit.  
Furthermore, TB caused women to be ashamed of themselves. Because of the 
social stigma attached to contracting TB, most patients would first seek home 
remedies such as eating bats and frog meat, drinking juice of basil leaves in hot 
water, wearing amulets, rubbing with hot oil and garlic, and when these methods 
failed, they resorted to outside help such as drug dealers, village doctors or 
herbalists. If all these measures failed, they would consult medical help as a last 
resort. Women participants, however, would seek help in secret. This was because 
of the greater social stigma attached to women sufferers. Many experienced mental 
suffering which was caused by the thought of dying and fear of social neglect 
especially in the case of women sufferers, who feared that their husbands would 
leave them. Both male and female sufferers felt that they would face ostracism, 
denial and apathy by the community. This led to different forms of mental torture 








In a study conducted in Peru, it was found that depression, low social support, poor 
quality of life and substance use were the main barriers to adherence in 
impoverished HIV-TB  co-infected people (Shin et al., 2008). Studies  done in 
Russia found that certain social, psychological and behavioural characteristics of 
TB patients, such as being male, unemployed, having a technical college 
education, a history of imprisonment, a bad mood or  mood swings, having little 
confidence in medical staff, not believing that they will fully recover, and reluctance 
to continue treatment ,had all contributed to non-adherence (Atun et al., 2005, 




2.5 Perceptions, attitudes, and psychosocial impact  of TB on health care 
providers, in particular medical doctors. 
  
Health care workers are at greater risk for TB, including multidrug-resistant TB 
(MDR-TB), compared to the general population (O' Donnell et al., 2010). The 
psychosocial impact of nosocomial TB on HCWs has received little attention in the 
literature (Padayatchi et al., 2010). These researchers found  five main themes 
emerging from their case study on five medical doctors who had contracted TB 
whilst on duty viz. prolonged morbidity,  psychological impact,  poor infection 
control,  weak support structures, and attrition from the clinical field as medical 
doctors. Prioritisation of TB infection control measures and strict practice according 
to universal guidelines have been highlighted in this and other studies (Naidoo and 





2.6 Interventions or programmes to minimise nosocom ial transmission 
 
Physicians and other health care workers are at constant risk to nosocomial 
transmission of Mycobacterium tuberculosis, especially because of their nature of 
work among patients with active tuberculosis and concomitant HIV infection and 
associated opportunistic infections. The extent of this risk varies from country to 
country, and is dependent on the prevalence of tuberculosis and HIV in the 
community, the area of work, type of clinical duties, and the effectiveness of local 
infection control measures(Rao et al., 2004, O' Donnell et al., 2010). These 
researchers have endorsed the call by others for prompt effective treatment of 
smear-positive TB patients in all health facilities with standard drugs provided the 
organism is drug-sensitive. 
Non-existent or inadequate control measures have been shown to influence the 
transmission of Mycobacterium tuberculosis in developing or resource constrained 
countries (Naidoo and Jinabhai, 2006, Abdool Karim et al., 2009, Padayatchi et al., 
2010). Unlike many other countries in the world such as the United States of 
America(USA) , South Africa does not have any officially standardised guidelines 
concerning control of nosocomial infections (Naidoo and Jinabhai, 2006). The 
implementation of the Centers for Disease Control( CDC) guidelines ( published in 
1994)  had led to a decrease in nosocomial transmission of tuberculosis in the USA 
(Centers for Disease Control and Prevention). It has been suggested that these 
guidelines be integrated into the current South African legislation addressing 
occupationally acquired diseases, and that this should be part of a broader effort to 
alleviate the current burden of nosocomial tuberculosis among HWCs (Naidoo and 












3.1 Study design 
 
This was a descriptive analytical cross-sectional study with qualitative and 
quantitative components. 
 
3.2 Study setting 
 
KwaZulu-Natal, South Africa. 
 
3.3 Target Population 
 
Medical doctors working in Kwazulu-Natal, South Africa. 
 
3.4 Study Population 
 
Medical doctors, working in Kwazulu-Natal, who were diagnosed and treated for 
tuberculosis between 1 January 2007 and 31 December 2010. 
 




i. Medical doctors working in Kwazulu-Natal who were diagnosed 
and treated for tuberculosis from 1 January 2007 to 31 December 
2010. 
ii. All those above who have been identified and who had given 





Medical doctors working in Kwazulu-Natal diagnosed and treated for tuberculosis 
before 1 January 2007. 
 
3.6 Sampling methodology 
 
 
3.6.1 Method of selecting sample   
 
A “snowball method” of sampling was used.  Doctors were addressed generally 
during official professional meetings by doctor groupings. Eligible doctors treated 
for TB during the study period and who identified themselves via this technique 
were thereafter contacted telephonically, informed of the nature of the study and the 
study objectives (using the information document) and were formally invited to 
participate in the study.  
 
3.6.2 Size of sample 
 
The study sample comprised all doctors recruited consecutively and who agreed to 
participate in the study. At least 100 participants were initially expected to 
participate. The consulting biostatistician was not able to calculate a sample size 
mainly because of the bi-modal study design with quantitative and qualitative 




3.7 Data sources 
 
3.7.1 Measurement instruments/Data collection Techn iques  
 
 
Data was collected using a semi-structured questionnaire (Annexure A1). The 
questionnaire was self- designed and was conducted in English. It comprised open 
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and closed ended questions; each participant was expected to complete the 
questionnaire within 15 minutes. The questionnaire was first piloted using a sample 
of five doctors who were infected with tuberculosis prior to 2007; necessary 
amendments were made thereafter. The modified questionnaires were self-
administered by the participants.  
 
3.7.2 Measures to ensure validity 
 
 
The questionnaires were standardized and applied to every participant in a similar 
manner. 
Participant selection bias was minimised by the informality of the initial approach to 
all doctors in social or professional meetings, and the recruiting of consecutive 
doctors identified in this way. Doctors who expressed any reservations about 
potential stigmatisation and victimisation excluded themselves from the study. 
 
3.7.3 Data collection and handling 
 
 
Potential participants were contacted telephonically and invited to participate in the 
study. The researcher arranged an appointment with the participant. The aim and 
the objectives of the study were explained to the potential participant by the 
researcher using the patient information sheet. Participants completed the informed 
consent form.   
 
The researcher then issued the questionnaire to the participant. The questionnaire 
was self-administered by the participant at his/her convenience. Each participant 
was requested to place the completed questionnaire into a sealed envelope. These 
envelopes containing the completed questionnaires were personally collected by 
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the researcher at a later date that was mutually agreed upon by the researcher and 
each of the participants. 
 
The completed questionnaires have been kept in a secure place and the 
information obtained has not been linked to any individual’s identity. These 
questionnaires have been secured by the researcher for a period of five years. 
There were no identifiers in the questionnaires or envelopes which could have 
linked them to the participants. 
 
3.8 Plan for Data handling/ processing 
 
 
All data was captured using the Statistical Software Package for Social Sciences 
(SPSS version19, IBM Inc. Chicago, Illinois, USA), and was analysed for statistical 
significance by the consulting biostatisticians (Ms Tonya Esterhuizen and Mr 
Stephan van der Linde) at the University of KwaZulu-Natal. 
 
The quantitative variables were analyzed using descriptive summary statistics such 
as mean, standard deviation and range, whilst frequency tables and percentages 
were used for categorical variables. 
 
 3.9 Limitations of the study 
 
 
Several limitations were recognised as the study progressed and reached finality. 
These are listed as follows: 
i. It was not possible to track all doctors who were infected with 




ii. Many doctors identified as eligible participants refused to participate in 
the study for various reasons especially those related to possible 
stigmatisation. 
 
iii. The use of self- administered questionnaires (viz. drop and pick- up 
method) in studies is frequently associated with low response rates.  
Notwithstanding the precautions taken by the researcher to personally 
collect the completed questionnaire from the participant, a number of 
participants reneged on their promises and did not meet appointments 
or comply with the agreed plan. They were therefore excluded from 
the study. 
 
iv. Self-administered questionnaires also carry an additional risk viz. 
quality assurance in terms of completion of questionnaires.  Since 
participants placed completed questionnaires in sealed envelopes, the 
researcher was not able to ascertain if all questions in the 
questionnaire were fully completed. 
 
3.10 Ethical considerations 
 
 
The study received ethical approval from the Biomedical Research Ethics 
Committee (BREC) of the College of Health Sciences, University of KwaZulu-Natal 
(approval number BF 097/09), and approval from the Post-graduate committee at 
the Nelson R Mandela School of Medicine (Annexures B 1-2). 
Written informed consent was obtained from each participant (Annexure B 3). Each 
participant was assured of confidentiality and security of all data collected. 
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All collected and analysed data have been stored in a safe by the researcher, and 









The results are presented as follows: 
 
i. socio-demographic profile of participants 
 
ii. clinical presentations of participants, investigations and time to diagnosis 
 
iii. iatrogenic side-effects and complications following procedures 
 
iv. perceptions and reflections of overall experiences of participants 
 
 
4.1 Socio-demographic profile of participants 
 
 
Sixty two medical doctors were identified as being eligible to participate in the 
study. However, only 40 questionnaires were returned for analysis. The socio-



















Table 1: Demographic profile of participants 
 
 
The majority of the participants were of Indian descent (n=34; 85%), in the younger 
age group viz. 21-40 years (n=34; 85%), male (n=21; 52.5%), and employed in the 
public sector (n=38; 95%). Two (5%) participants were employed in either private 
hospitals or general practice. Twenty seven doctors (67.5%) were employed in 
specialist designated regional or tertiary public hospitals in KwaZulu-Natal; the 
remainder (n=10; 27.5%) worked in primary care (level 1) facilities.  Most of the 
participants (>70%) worked in medical disciplines one month prior to developing the 
Variable  Male Female Total  
 n % n % n % 
Number of participants  21 52.5 19 47.5 40 100 
Age (years) groups:        
     21 – 30 10 47.6 11 57.9 21 52.5 
     31 – 40 7 33.3 6 31.5 13 32.5 
     41 – 50 0 0 1 5.3 1 2.5 
     51 – 60 3 14.3 0 0 3 7.5 
     61 – 67 1 4.8 1 5.3 2 5 
Race:        
     Black 3 14.3 0 0 3 7.5 
     Indian 17 81.0 17 89.4 34 85 
     Whites 1   4.7 2 10.5 3 7.5 
Employment:        
      Public 20 95.2 18 94.7 38 95 
      Private 1 4.8 1 5.2 2 5 
Employment  Public  sector:        
      Primary Healthcare 0 0 1 5.6 1 2.6 
      District level 6 30.0 4 22.2 10 26.3 
      Regional level 5 25.0 8 44.4 13 34.2 
      Quaternary level 9 45.0 5 27.8 14 36.9 
Still on anti -TB treatment  4 19.1 6 31.6 10 25.0 
Discipline worked -  1 month prior:          
Medical 16 76.2 13 68.4 29 72.5 
Surgical 4 19.0 4 21.1 8 20.0 
     Other : GP 0 0 1 5.3 1 2.5 
 Missing information 1 4.8 1 5.2 2 5.0 
Discipline  worked - at time of 
diagnosis       
    Medical 16 76.2 10 52.7 26 65.0 
    Surgical 4 19.1 7 36.9 11 17.5 
    Other  : GP 0 0 1 5.2 1 2.5 
    Missing information 1 4.7 1 5.2 2 5 
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initial symptoms of their illness.  Only two of the participants worked either in a TB 
clinic or TB in-patient ward.  There were no statistical differences between male and 
female participants in any of the various categories shown in Table 1. 
 
 
4.2 Clinical presentations and investigations 
 
 
The symptoms and signs were grouped into two categories i.e. those that are 
generally accepted as common findings associated with tuberculosis infection, and 
those that are not are not commonly documented in the literature (Table 2).  
Malaise was reported to be the most common presenting symptom in 22 (55%) of 
all participants. Night sweats (n=21; 52.5%) and unexplained weight loss (n=22; 
55%) were also highly ranked. More males reported these symptoms when 
compared to their female counterparts in the study sample. Only 4 participants 
reported fever as a presenting symptom. Other common symptoms were chronic 
cough (n=19), pleuritic chest pain (n=14), lymphadenopathy (n=12) and dyspnoea 
(n=8). Less common and unusual presentations that were reported included 
















Table 2: Clinical presentations at baseline 
 
 Males                  Females      Total (N)  













Cough  11 52.3 8 42.1 19 
Fever  1 4.7 8 42.1 9 
Headache  2 9.5 4 21.0 6 
Lymph  nodes  4 19.0 8 42.1 12 
Loss of weight  11 52.3 9 47.3 20 
Malaise  14 66.6 8 42.1 22 
Night sweats  13 61.9 8 42.1 21 
Shortness of 
breath 
3 14.2 5 26.3 8 




The investigations performed at initial presentation are listed in Table 3. An analysis 
of the commonly done investigations which are part of the national standard of care 
shows that sputum microscopy was requested in 70% (n=28) of the participants, 
and chest radiographs were performed in 38 (95%) of all participants. 
Other investigations or diagnostic procedures that were performed on some of the 
participants included the following:  upper endoscopy in one participant who 
presented with dysphagia, bronchoscopy in 2 participants and mediastinoscopy in 1 
participant. Fifteen participants (37.5%) underwent chest cat scans during the 
diagnostic period. One participant had consulted a rheumatologist because of 
persistent arthralgia whilst on treatment, and was subjected to an MRI full body 

























CT Scan (chest)  15 37.5 
Tiss ue biopsy:  microscopy  
                            Culture 
14 35.0 
9 22.5 
Pleural fluid chemistry  8 20.0 
Pleural fluid microscopy  7 17.5 
Pleural fluid culture  7 17.5 
Quantiferon Gold in -tube test  3 7.5 
Other  investigations  8 20.0 






Eight (20%) doctors reported complications that had developed as a result of 
procedures conducted on them. These complications included the following:  
haemoptysis and pleuritic chest pain following bronchoscopy; cellulitis at biopsy site 
of lesion; development of a chest wall abscess at biopsy site; a chronic draining 
sinus from lymph node biopsy site; and injury to the participant’s neurovascular 
bundle on insertion of an intercostal chest drain and performing a pleural biopsy. 
 
An analysis of lag time from onset of symptoms to definitive diagnosis (Table 4) 
showed that only 23.8% of males and 15.8% of female participants were diagnosed 













 n % n % 
<8 5 23.8 3 15.8 
8 - 21 6 28.6 5 26.3 
>21 10 47.6 11 57.9 
                  
 
 
There were no statistically significant differences between male and female 
participants for this variable. A total of 32 participants were diagnosed beyond day 
21.Thirty five percent (n=14) of all participants thought that the delays in diagnosis 
were inappropriate. Further analysis of this finding showed that five participants 
(12.5%) felt that the delay in diagnosis was due to delayed and inappropriate help-
seeking behaviour; eight participants (20%) felt that their care giver had either 
delayed or omitted to investigate them earlier, and two participants felt that they 
were wrongly diagnosed. 
 
 





Table 5 lists the side effects experienced by the participants during their treatment 
phase.  A total of 84 iatrogenic side-effects were reported by 33 (82.5%) 
participants. These were mainly abdominal pain and symptoms of gastritis in 10 
participants (25%); nine (22.5%) had continuing malaise while on treatment, 
peripheral neuropathy (n=7; 17.5%), skin rashes (n=7; 17.5%), new onset arthralgia 
(n= 5; 12.5%), toxic hepatitis (n=3; 7.5%) and photophobia (n=2; 5%).  Of the 21 
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(52.5%) participants who complained of nausea and vomiting, 12 (63.1%) were 
females and 9 (42.8%) were males.  
 
Nine participants who developed symptoms following tuberculosis treatment self-
medicated with homeopathic medicines and complimentary therapy in an attempt to 
alleviate these symptoms while on concurrent anti-tuberculosis therapy. 
 
Table 5: Side effects of prescribed medications 
 
         Males            Females  
Side effect  (n) (%) (n) (%) 
Abdominal pain  1 4.7 9 47.3 
Arthralgia  2 9.5 3 15.7 
Diarrhoea  1 4.7 4 21.0 
Dizziness  1 4.7 0 0 
Drowsiness  0 0 3 15.7 
Gout  0 0 1 5.2 
Headache  0 0 1 5.2 
Hepatitis  2 9.5 1 5.2 
Insomnia  1 4.7 1 5.2 
Malaise  3 14.2 6 31.5 
Metallic taste  1 4.7 1 5.26 
Myopathy  1 4.7 1 5.26 
Nausea, vomiting  9 42.8 12 63.1 
Peripheral neuropathy  3 14.2 4 21.0 
Photophobia  0 0 2 10.5 






4.5 Perceptions following diagnosis and treatment  
 
 
All participants provided reflective responses to leading statements; these were 
related to their experiences during the phases of diagnosis, treatment and 
management following the contraction of nosocomial tuberculosis. These are listed 
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A number of participants felt that medical doctors received preferential 
consideration for specialized diagnostic procedures (n=30; 75%) and generally 
received preferential treatment (n=18; 45%), compared to the rest of the population.  
The majority of participants (n=36; 90%) reflected that their personal experiences 
as patients with tuberculosis influenced them to modify their attitudes and clinical 
approaches to their current patients. Whilst the majority of the participants admitted 
that their own experiences have re-moulded them towards becoming more 
empathic doctors, a minority (n=4) preferred to be non-committal on this issue. 
Additional reflections focussed on further risk minimisation, future career changes 
and attitudes towards patients and the public health system. For example, one 
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doctor had since left clinical medicine and found employment either in a laboratory 
facility without patient contact, for fear of placing herself at further risk.  She 
regretted her decision to practise medicine. Another doctor expressed similar 
feelings and listed specific events during his illness of how inappropriately he was 
treated by his fellow colleagues at work.  He mentioned that he was criticised for 
taking sick leave and was forced to cover up hours that he missed as soon as he 
returned to work.  This sentiment was echoed in several other responses as some 
senior medical colleagues felt that sick leave was a privilege and not an entitlement.  
In addition, he reported that his confidentiality was not maintained. He felt so bitter 
about his experience that he too has sought employment in a field with no patient 
contact.  
One participant felt “angry” when having to treat patients who were infected with TB 
and HIV. He admitted to feelings of resent toward them as he felt they were in part 
“responsible” for him becoming infected. 
“Having TB has been one of the most debilitating experiences of my life,” expressed 
one of the participants. Another participant lamented the attitudes of other 
colleagues and said, “Our task as doctors is to assist with healing others. It hurts 
when our own well-being is jeopardized through an illness (that we have contracted 
in trying to provide a service to others), and our colleagues and management show 
an uncaring attitude towards us!”   
Only two of the 40 participants were aware of the current national regulations for 
compensation of tuberculosis infection in South Africa according to the 
Compensation for Occupational Injuries and Diseases Act (COIDA). One participant 





DISCUSSION AND CONCLUSION 
 
 
This chapter presents a discussion of the main findings, limitations of the study, 
implications and conclusions linked to the study. The discussion on the main 




5.1 Socio-demographic profile of participants  
 
In this study, the majority of participants were in the younger age group and 
employed within medical departments in the public health care system, either 
immediately before or during presentation with symptoms or signs of TB. This is not 
surprising considering that the majority of patients with TB generally access these 
medical departments in hospitals first for their help-seeking needs, thereby acting 
as vectors in the transmission of infection. Doctors and nurses are generally the 
primary care givers in general medical wards and outpatient facilities. Similar 
findings have been made in other studies (Wilkinson and Gilks, 1998, Joshi et al., 
2006, Naidoo and Jinabhai, 2006, O' Donnell et al., 2010, Padayatchi et al., 2010). 
Occupational exposure towards TB constitutes a major health hazard for all health 
care workers throughout the world, and particularly in developing and resource-
constrained countries or settings (Joshi et al., 2006). This risk is increased in 
settings with  a high burden of communicable diseases such as HIV and TB 
including varying forms of drug resistant TB and lack of  adequate infection control 
measures (Wilkinson and Gilks, 1998, Naidoo and Jinabhai, 2006, Joshi et al., 
2006, O' Donnell et al., 2010, Padayatchi et al., 2010). Workers in TB inpatient 
facilities, medical wards and outpatient medical facilities have been shown to be at 
higher risk for TB disease compared to the general population(Joshi et al., 2006). 
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Increasing age and duration of employment  in the healthcare facility (indicating 
longer cumulative exposure to TB) were associated with a higher prevalence of 
TB(Joshi et al., 2006). The majority of participants in our study worked in similar 
settings with a high burden of TB and HIV, and were therefore placed at greater risk 
than other categories of healthcare staff. 
 
5.2 Clinical Presentation, Help-seeking behaviour a nd Management of 
Participants  
Our study found a large number of doctors had not taken seriously the cluster of 
symptoms generally accepted as being suggestive of tuberculosis infection, thus 
delaying their diagnosis and definitive treatment. One would have expected that all 
medical doctors (aware of the current burden of infectious disease) would be 
prompted by a higher index of suspicion to immediately investigate their own 
symptoms of cough, night sweats, etc. All of the participants in this study were HIV 
uninfected, and the majority presented with non-specific symptoms and signs. 
Health care workers may therefore understandably find it difficult to differentiate 
these non-specific symptoms from work-related fatigue or other mild illnesses, if 
one considers the current context of working in a resource constrained working 
environment in the public health care system in South Africa which is additionally 
burdened by increasing numbers of immune-compromised patients. For example, 
as one participant stated, “I neglected the symptoms due to the pressures of 
work…stress, physical exhaustion, 10-12 calls per month, sleep deprivation and 
inappropriate diet”.  It has been suggested that “many doctors may be reluctant to 
admit that they are ill and may be especially unwilling to acknowledge that their ill 
health is affecting their performance at work”. Additionally, doctors may experience 
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high levels of shame associated with being ill, and this may influence delays in 
seeking help (Sexton et al., 2001).  
Many studies have been carried among the general populations towards their 
experience of contracting TB. Denials by patients of having contracted or suffering 
from tuberculosis has been an ongoing problem (Rowe et al., 2005, Jakubowiak et 
al., 2008, Karim et al., 2011). Tuberculosis related stigma has been shown to 
worsen the quality of life of patients with consequential effect on health or even help 
care-seeking behaviour (Somma et al., 2008, Weiss et al., 2008).  Certain types of 
social consequences (unemployment, homelessness, imprisonment or poverty) and 
psychological effects (low morale, depressed mood, mood swings and having little 
confidence in medical staff) could account for the poor adherence to treatment or 
even inappropriate help-seeking behaviour (Jakubowiak et al., 2008, Shin et al., 
2008). Another study found that patients were not adequately educated about the 
cause of TB, and those who were diagnosed felt embarrassed about contracting the 
disease. In addition, the negative attitudes of certain health care staff discouraged 
them from seeking treatment earlier (Rundi, 2010).  
 
One would have expected tests such as chest x-rays and sputum analysis to have 
been conducted in all these subjects as part of the standard care of practice in the 
national health care system (National Department of Health, 2007). However, this 
did not occur in all participants. It is possible that participants who could not 
produce sputum were sent for alternate tests. Additionally, because these tests 
were found to be negative in the majority of participants, their care-givers opted for 
a variety of costly investigations such as Quantiferon Gold in-tube test, chest cat 
scans (33.5%), bronchoscopy, mediastinoscopy, etc., which are not normally 
available to the general public for similar presentations. The Quantiferon Gold in-
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tube test has been found to have a low sensitivity in the diagnosis of active TB 
(Legesse et al., 2010). Perhaps, awareness of the high prevalence of extra-
pulmonary disease especially in immuno-compromised patients in the general 
population, and the risk of nosocomial infections may have influenced care givers of 
these participants to opt for these procedures. Many participants gained access to 
specialized procedures for diagnosis of TB, which are usually reserved for 
exceptional cases. A number of participants  in this study concurred  that medical 
doctors are generally  given preferential treatment by their colleagues and are more 
likely to access specialized levels of care than the general population,  and that the 
search for a diagnosis is amplified when the patient is a medical doctor.  
 
5.3 Perceptions and reflections following TB treatm ent 
Strict adherence to anti-TB therapy forms the cornerstone of the nationally 
accepted clinical guideline in TB management (National Department of Health, 
2007). All clinicians spend most of their clinical time counselling patients on this 
most important aspect of clinical care. It is therefore disconcerting that a large 
number of participants displayed varying responses and attitudes to relevant 
statements relating to adherence. Thirteen (32.5%) participants in this study 
considered defaulting their treatment and a further 11(27.5%) had modified their 
therapy to suit their personal needs.  Twenty seven (67.5%) participants admitted to 
difficulty in enduring their treatment. These responses may have been influenced by 
side effects commonly associated with prescribed anti-TB drugs, and by 
concomitant high stress levels including varying levels of depression. Similar and 
additional risk factors for defaulting treatment  were identified  among a cohort of 
elderly patients suffering with depression in Malaysia (Rashid and Rahmah, 2010). 
Among the risk factors identified with the default of drug treatment in this study 
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included side effects from medicines, not being given a choice to choose the 
treating doctor, and not being happy with the prescribed treatment. Additionally, 
long waiting times and varying problems with the health facility were considered 
potential risk factors.  
The current South African national guidelines mention that those with increased risk 
of developing drug-induced hepatitis are patients with chronic infectious hepatitis, 
patients with pre-existing liver disease,  patients with high levels of alcohol 
consumption, females, HIV infected patients and patients who are receiving other 
hepatotoxic drugs as well as those patients older than 35 years of age. In our study, 
only five participants were found to have concurrent co-morbid lifestyle illnesses 
such as Diabetes mellitus, Asthma, etc., but none had any of the illnesses 
mentioned above which could have placed them at risk. 
 
Twenty-two (55%) of all participants described gastro-intestinal side-effects such as 
nausea, vomiting, etc.; these could have been due to any of the constituent drugs 
present in the combination drug formulations currently in use as first line drugs. 
Seven patients (17.5%) in the study were diagnosed with peripheral neuropathy; 
these could have been due to either isoniazid and / or ethambutol which are part of 
the standard regimen of drugs used. 
 
One of the participants in this study had persistent arthralgia which necessitated 
self-referral to a rheumatologist. Pyrazinamide and ethambutol are commonly 
associated with hyperuricaemia and arthralgia; this is usually self-limiting and rarely 




The study also produced a refreshingly positive finding, in that the majority of 
subjects were influenced and humbled by their own experiences as patients to such 
an extent that they had decided to modify their own approach to patients in future. 
 Thirty six  participants (90%) had already decided that they would become more 
patient-centred and improve the doctor-patient relationship in future consultations; 
however, a minority of subjects felt the high burden of disease and increased 
burden of care by a limited and constrained medical workforce militated against a 
change in professional behaviour towards patients. Similar findings have reported in 
other studies, where medical doctors felt their personal experiences helped them 
empathise and communicate with patients (Kern et al., 2001, Woolf et al., 2007). It 
is believed that personal experience of illness may improve doctors’ empathy, 
patient-centredness and professional behaviour, possibly via reflection and 
transformational learning processes (Woolf et al., 2007). 
 
5.4 Nosocomial TB and COIDA 
This study did not explore the source of TB contraction in the participants, and 
therefore cannot confirm that all participants had nosocomial TB. Considering the 
context of the work environments of all participants and the high burden of 
communicable infectious diseases in these settings, it is possible that all 
participants either had nosocomial infection or reactivation of pre-existing TB. 
  
Nosocomial tuberculosis   has been gazetted a compensatable disease by the 
Compensation for Occupational Injuries and Diseases Act in South Africa. Only two 
subjects in the study were aware of this, and one of them is still awaiting a written 
response to a claim despite many requests. Another has been informed that COIDA 
would not compensate any medical doctor for extra-pulmonary TB, and where the 
36 
 
cause has not been verified as nosocomial. This response appears to be similar to 
other anecdotal experiences by other medical doctors outside this study. Increased 
advocacy by the medical profession may influence a policy change and swift 
response to enquiries in this regard. 
 
5.5 Limitations of the study 
This study had several limitations. The study sample was small and therefore 
precluded a more extensive quantitative analysis for statistical differences and 
significance of some of the parameters studied. Many eligible participants (n=22) 
cited stigmatization in social and professional circles as well as victimization at the 
place of employment and therefore decided to withdraw their initial intention to 
participate. Only a minority of doctors (30.8%) from the primary health care sector 
of the public health care system volunteered to participate. This may not be 
representative of the true picture when matched against the current prevailing 
background of a large burden of disease in primary care. The “snow-ball” method of 
sampling has inherent biases. The results of this study cannot be generalized to the 
broader population of medical doctors because of the limitations in the study 
design, subject recruitment and sample size. A broader more extensive study is 
therefore recommended. 
 
5.2 Implications of Study and Conclusion 
 
This study has confirmed previous published reports that  TB  among medical 
doctors is a serious personal, professional and public health issue,  and endorses 
the view that it  must be addressed more vigorously by both policy makers and by 
the medical profession (Colvin et al., 2001, Naidoo and Jinabhai, 2006, Padayatchi 
et al., 2010). 
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 Suitable infection control measures, effective screening, early diagnosis, proper 
treatment and management of TB infection in HCWs, particularly doctors and 
nurses who come into close contact with TB patients and education of HCWs about 
TB, have been shown to be effective  in reducing the incidence and prevalence of 
TB in this vulnerable group (Centers for Disease Control and Prevention, Torres 
Costa et al., 2010). Perhaps, the introduction of a screening  programme similar to 
that carried out in Portugal may produce a similar outcome of decreasing  the 
incidence of TB in health care workers (Torres Costa et al., 2010). Additionally, 
transmission control measures recommended by the Centers for Disease 
Prevention (2005) should be integrated and implemented into the South African 
guidelines for the management of TB.  
Pre-employment screening of all HCWs for TB and regular surveillance of HCWs 
within an employee assistance programme in all health facilities are strongly 
recommended. If implemented and standardized throughout South Africa, this 
infection control programme is expected to impact positively on early detection and 
rapid treatment of HCWs with nosocomial TB. It will also help to differentiate 
between nosocomial transmission of TB and reactivation of pre-existing disease, 
and facilitate rapid resolution of problematic case enquiries by COIDA. 
The risk of drug resistance and the emergence of new resistant strains of 
Mycobacterium tuberculosis further emphasises the need for these measures to be 
standardized in order to minimise the transmission of tuberculosis within health 
facilities.   
Senior medical colleagues and hospital management in all health care facilities are 
advised to adopt a more caring and compassionate approach towards medical 
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ANNEXURE A 1 
 
 
QUESTIONNAIRES: All questionnaires must be submitted with this 
form  
 
TUBERCULOSIS IN MEDICAL DOCTORS IN KWA-ZULU NATAL ( S.A.):  
EXPERIENCES AND PERCEPTIONS TOWARDS DIAGNOSIS AND T REATMENT 
 
 
SECTION A:  DEMOGRAPHIC INFORMATION  
 



















Q4.  EMPLOYED IN   PRIMARY HEALTH CARE CLINIC 
 
 
DISTRICT LEVEL FACILITY 
 
 
















Q5.  I WAS WORKING IN…… 
 A MONTH PRIOR TO 
DIAGNOSIS 
AT THE TIME OF MY 
DIAGNOSIS 
CLINICAL DISCIPLINE  
 
 




Q6.   HAVE YOU BEEN DIAGNOSED WITH ANY OTHER CHRONI C MEDICAL 
CONDITIONS? 
 




Q7.  IF YES TO Q6, PLEASE INDICATE 
 
DIABETES      HYPERTENSION 
 
 
ISCHAEMIC HEART DISEASE   ASTHMA 
 
 
EPILEPSY      OTHER 
 
 







Q6.  WHEN DID YOU DEVELOP SYMPTOMS OR SIGNS SUGGESTIVE OF         



















SECTION B:  SYMPTOMS AT ONSET OF ILLNESS 
 
Q8.  LIST SYMPTOMS OF ONSET OF ILLNESS 
 
CHRONIC COUGH     ABDOMINAL PAIN 
 
 
PLEURITIC CHEST PAIN    HEADACHE 
 
 
DYSPNOEA      SWOLLEN LYMPH NODES 
 
 
LOSS OF WEIGHT     NIGHTSWEATS 
 
 
GENERALIZED MALAISE    OTHER 
 










SECTION C:  CLINICAL SIGNS AT TIME OF PRESENTATION  
 
Q9.  LIST CLINICAL SIGNS AT TIME OF PRESENTATION 
 
CHEST (e.g. pleural effusion, pneumonia etc) 
 
  _____________________________________________ 
 
  _____________________________________________ 
 
CVS (e.g. pericardial effusion etc) 
 
  _____________________________________________ 
 
  _____________________________________________ 
 
ABD (e.g. focal lesions in liver, spleen; intra-abdominal lymph nodes; ascites; etc) 
 
  _____________________________________________ 
 
  _____________________________________________ 
 
CNS 
 (e.g. meningism; focal neurological deficit; space occupying intracranial lesion; etc) 
 
  _____________________________________________ 
 




  _____________________________________________ 
 
  _____________________________________________ 
 
OTHER    _________________________________________________ 
 







SECTION D:  INVESTIGATIONS 
 
Q10.   INDICATE THE INVESTIGATIONS CARRIED OUT  ON YOU AT INITIAL   
TIME OF PRESENTATION OF YOUR SYMPTOMS.  
 
 INDICATE BRIEF FINDINGS OF TESTS DONE ON YOU BEFOR E YOU WERE 
DIAGNOSED WITH TUBERCULOSIS.   











TISSUE BIOPSY     MICROSCOPY 
 
 
TISSUE BIOPSY CULTURE 
 
 
LUMBAR PUNCURE  CSF CHEMISTRY 
 
    CSF   MICROSCOPY 
 




PLEURAL FLUID  CHEMISTRY 
     
    MICROSCOPY 
 
























Q11.  DID THE INITIAL DIAGNOSIS INDICATE YOU HAD TB ? 
 
 
  YES      NO 
 
 
Q12.  IF ANSWERED “ NO”  IN Q14 ABOVE, WHAT WAS THE DIAGNOSIS?   
(Tick relevant answers) 
 
  EBSTEIN BARR VIRUS 
 
 
  BRONCHITIS 
 
 
  PNEUMONIA 
 
 
  SUSPECTED CANCER 
 
  OTHER 
 
  IF OTHER, PLEASE SPECIFY__________________________ 
 
  ___________________________________________________ 
 
 
Q13.   WHAT WAS THE REASON FOR THE MISDIAGNOSIS?   
(Tick relevant answers) 
 
 
  LYMPH NODE BIOPSY WAS NEGATIVE 
 
 
  AFB TEST/S WERE NEGATIVE 
 
 
  OTHER 
 
  IF OTHER, PLEASE SPECIFY  ________________________ 
 
  __________________________________________________ 
 
 
Q14.  LOOKING BACK IN TIME WHEN THE ABOVE PROCEDURE /S OR TEST/S   
WERE DONE, DID YOU DEVELOP ANY COMPLICATIONS? 
 
 
  YES     NO 
 
   




  ______________________________________________________ 
 
  ______________________________________________________ 
 
 
Q15.    FROM A MEDICAL DOCTOR’S VIEW, IS IT COMMON FOR AN 
AVERAGE PATIENT TO DEVELOP SUCH COMPLICATIONS? 
 
  YES    NO 
 
 




  YES    NO 
 
 
Q17.   IF YES TO Q20 ABOVE, WHY WAS IT NECESSARY FO R A SECOND  
 OPINION?  (Tick relevant answer) 
 
  You were not comfortable with the initial diagnosis 
 
   
  To ensure that the diagnosis was correct 
 
   
  You did not have confidence in the first doctor/consultant 
 
 
  Other 
 
  If other, please specify  _________________________________ 
 
  ____________________________________________________ 
 




SECTION E:  LAG TIME  
 
Q18.   TIME FROM ONSET OF SYMPTOMS TO DIAGNOSIS (Tick correct answer) 
 
7 DAYS     8-14 DAYS 
 
 
15-21 DAYS     22-30 DAYS 
  
 




Q19.  IF TIME LAG WAS  MORE THAN 14 DAYS, STATE WHAT CAUSED THE      
          DELAY.   
 (Tick relevant answer) 
 
  Due to a delay in obtaining a second opinion 
 
   
The initial test/s were not confirmatory for making a diagnosis 
 
   
The tests were not conducted according to the guidelines set 
 
   
Delay in accessing or receiving results of tests done 
 
   
Other 
 
  If other, please specify _____________________________ 
 
  ________________________________________________ 
 
 
Q20.  WAS THE DELAY APPROPRIATE? 
 
  YES     NO 
 










SECTION F:  TREATMENT 
 
Q21.  TIME FROM DIAGNOSIS TO INITIATION OF TREATMEN T 
 (Tick relevant answer) 
 
1-7 DAYS    8-14 DAYS 
 
 
15-21 DAYS    22-30 DAYS 
 
 




Q22.  IF MORE THAN 7 DAYS, STATE THE REASON FOR THE  DELAY 
 (Tick relevant answer) 
 
  MEDICINE NOT IN STOCK 
 
 
  NON-AVAILABILITY OF ATTENDING DOCTOR 
 
 
  OTHER 
 
  IF OTHER, PLEASE SPECIFY  _______________________ 
 
  _________________________________________________ 
 
  _________________________________________________ 
 
Q23.  WERE YOU HAPPY WITH THE REASON GIVEN TO YOU FOR THE 
DELAY? 
 
  YES     NO 
 
  









SECTION G:  TREATMENT REGIMEN 
 
Q24.   LIST THE NAMES OF DRUGS PRESCRIBED AND THE N UMBER OF 
MONTHS TAKEN FOR EACH DRUG  
 























SECTION H:  SIDE EFFECTS ON PHARMACOTHERAPY GIVEN  
(Tick the most appropriate response in each question) 
 
Q25.   DID YOU EXPERIENCE ANY SIDE EFFECTS FROM THE 
PHARMACOTHERAPY? 
 
    YES      NO 
 
 
Q26.   IF ANSWERED YES TO Q28 ABOVE, PLEASE SPECIFY …. 
 



























Q27.  DID YOU OBTAIN IMMEDIATE RELIEF OF ORIGINAL S YMPTOMS AFTER  
         COMMENCEMENT OF THE TREATMENT? 
 
  YES    NO 
 
 
Q28.  IF ANSWERED “NO” TO Q29 ABOVE, WHAT WAS THE REASON?  
 (Tick the relevant answer) 
 
  INAPPROPRIATE DIAGNOSIS 
 
   
  INAPPROPRIATE REGIMEN 
 
   





Q30.  WHAT WAS THE FINAL DIAGNOSIS 
 (Tick relevant answer) 
 
 
  TB 
 
 
  MDR TB 
 
  XDR TB 
 
 
Q31.  LIST THE SPECIFIC ANTI-TB DRUGS AND DOSAGES Y OU WERE 
COMMENCED   


















Q32.  DID YOU HAVE ANY COMPLICATIONS OR SIDE EFFECT S AS A RESULT OF 
THE  NEW REGIMEN? 
 
   YES    NO 
 
 














   
Q33.  DID YOU USE NON-PHARMACOLOGICAL MEASURES TO A LLEVIATE SIDE 
EFFECTS OF ANTI-TUBERCULOSIS TREATMENT?   (Tick relevant answer) 
 
   
   YES    NO 
 
  











Q34.  DID YOU SEEK THE ADVICE OF HOMEOPATHIC/ALTERN ATIVE MEDICINE 
PRACTITIONERS TO RELIEVE SIDE EFFECTS?   (Tick the relevant answer) 
 
 
   
   YES    NO 
 
  














Q35.   TUBERCULOSIS REQUIRES A LENGHTY PERIOD OF TR EATMENT.  I FOUND 
THE PERIOD OF TREATMENT DIFFICULT TO ENDURE.   (Circle relevant answer) 
 





Q36.  I CONSIDERED DEFAULTING MY PHARMACOTHERAPY DU RING MY 
TREATMENT      PERIOD.  (Circle relevant answer) 
 




 Explain your answer 
   ______________________________________________________ 
 
   ______________________________________________________ 
    
   ______________________________________________________ 
 
 
   
Q37.   I MODIFIED MY PHARMACOTHERAPY TO SUITE MY PE RSONAL NEEDS. 
 (Circle relevant answer) 
 





 Substantiate your answer 
   ______________________________________________________ 
 
   ______________________________________________________ 
 
   ______________________________________________________ 
 
 
Q38.  MEDICAL DOCTORS SUSPECTED OF BEING INFECTED W ITH TUBERCULOSIS      
 ARE MORE LIKELY TO HAVE ACCESS TO SPECIALIZED DIAG NOSTIC   
 PROCEDURES THAN THE REST OF THE PATIENT POPULATION . 
(Circle relevant answer) 
 





   ______________________________________________________ 
 




   
Q39.  MEDICAL DOCTORS ARE GIVEN PREFERENTIAL MEDICA L TREATMENT BY 
THEIR PHYSICIANS AS COMPARED TO THE GENERAL POPULAT ION.   
(Circle relevant answer) 




  ______________________________________________________ 
 
  ______________________________________________________ 
 
  ______________________________________________________ 
 
 
Q40.   MY PERSONAL EXPERIENCE WITH TUBERCULOSIS HAS  CHANGED THE  
 MANNER IN WHICH I MANAGE MY PATIENTS. 
 (Circle relevant answer) 




 SUBSTANTIATE YOUR ANSWER 
   ____________________________________________________ 
 
   ____________________________________________________ 
 
   ____________________________________________________ 
 
   ____________________________________________________ 
 
   ____________________________________________________ 
 
   ____________________________________________________ 
 
Q41.  WOULD YOU LIKE TO ADD ANY COMMENTS TO THE ABO VE INFORMATION, 
















Q42.  HAVE YOU RECEIVED ANY COMPENSATION FROM THE C OMPENSATION 
COMISSIONER COIDA SINCE YOUR ILLNESS?   
 
 














Q43.  HAVE YOU RETURNED TO WORK?   
 
 
YES    NO 
 
  











Thank you very much for participating in this study.  You have assisted me greatly in my 
understanding of patients’ experiences. 
 


















ANNEXURE B 3 
 
Study title:  Tuberculosis in Medical Doctors in Kw aZulu-Natal (S.A.): 
Reflections on personal experiences with regards to  their diagnosis and treatment 
 





I, (DR/PROF) _____________________________________________________(full 
name) have been invited to participate in this research study.   
 
An information document about this study has been given to me; the details of this study 
and my involvement have also been explained to me by the researcher, Dr Ashantha 
Naidoo. 
 
I am also aware that I may contact the researcher at any time during working hours if I 
have questions about the research or if I am affected as a result of this research. 
 
The contact numbers for the researcher are: 
 
(031) 360 3500 (W)  (CELL) 082 877 12 75 
 
 
I may contact the Biomedical Research Ethics Office  on 031-260 4769 or 260 1074  if I 
have questions about my rights as a research participant. 
 
My participation in this research is voluntary, and I will not be penalized or lose benefits if I 
refuse to participate or decide to stop at any point in this study. 
 
I agree to voluntarily participate in this research study.  I understand that I can stop 
participating in this study at any time that I may wish to without giving any explanation or 
being prejudiced in any way. 
 
I acknowledge that I have read this form in its entirety and that its contents have been 
explained to me.  I understand my responsibility in the research study in which I will be 
participating.  I accept the risks, rules and regulations set forth. 
 
Knowing these and having had the opportunity to ask questions which have been 





____________________      ____________________ 
Signature of Participant                            Date 
 
 
____________________   _____________________ 
Signature of Witness                                Date 
(Where applicable)      
 
 
